Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1, Randomized, Double-Blind, Placebo- and Positive-Controlled Study to Evaluate the Effect of Ozanimod on Pressor Response to Oral Tyramine in Healthy Adult Subjects

Next Previous
Trial Profile

A Phase 1, Randomized, Double-Blind, Placebo- and Positive-Controlled Study to Evaluate the Effect of Ozanimod on Pressor Response to Oral Tyramine in Healthy Adult Subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 26 Oct 2018

At a glance

  • Drugs Ozanimod (Primary) ; Phenelzine; Tyramine
  • Indications Crohn's disease; Multiple sclerosis; Ulcerative colitis
  • Focus Therapeutic Use
  • Sponsors Celgene Corporation

    • Most Recent Events

    • 19 Oct 2018 Planned End Date changed from 5 Mar 2019 to 8 Jan 2019.
    • 19 Oct 2018 Planned primary completion date changed from 6 Jan 2019 to 8 Jan 2019.
    • 10 Oct 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top